John G. Aunins, Chief Technology Officer & EVP at Seres Therapeutics, Inc. (MCRB), sold 28,564 shares at $6.39 ($183K) on 2018-12-17, disclosed to the SEC on 2018-12-19.
Open-market sale of $183k MCRB by Chief Technology Officer & EVP. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.39 | 14,282 | $91K | 50.0% |
| 2 | $6.39 | 14,282 | $91K | 50.0% |
| Total | $6.39 avg | 28,564 | $183K | 100% |
| Filing → |
| MCRB | SELL | 2018-09-19 | $655K | — | Filing → |
| MCRB | SELL | 2018-07-18 | $231K | — | Filing → |
| MCRB | SELL | 2018-06-18 | $245K | — | Filing → |